Hypenatremia in patients diagnosed with SARS-CoV-2: A literature review
DOI:
https://doi.org/10.33448/rsd-v13i8.46417Keywords:
Hydroelectrolytic disorders in COVID-19; Hypernatremia and COVID-19; Dysnatremia in SARS-CoV-2.Abstract
Introduction: Covid-19 is a disease caused by the new coronavirus, called SARS-CoV-2, an RNA virus, which presents a clinical spectrum ranging from asymptomatic infections to severe acute respiratory failure. Responsible for more than 421,316 deaths in Brazil since its discovery. Studies show significant differences between surviving and non-surviving patients related to total lymphocyte count, urea, CRP levels and D-dimer at admission, and non-surviving patients presented numerous alterations, including hypernatremia. The objective of the study is to review the bibliographical analysis of hypernatremia in patients with a confirmed diagnosis of Covid-19. Method: This is a literature review with searches in the Scielo and Pubmed databases for articles from the last 5 years that met the established inclusion criteria. Results and Discussion: Hospital studies report increased mortality in intensive care units associated with hypernatremia. Evidencing an association between hypernatremia and a higher mortality rate for patients with pneumonia in general. Hypernatremia is often a reflection of water loss rather than sodium gain, mainly due to dehydration due to increased body temperature. Conclusion: Hypernatremic patients have a higher rate of adverse effects such as thrombotic events and an increased mortality rate. Hypernatremia control protocols are encouraged.
References
Argenziano, M. G., Bruce, S. L., Slater, C. L., Tiao, J. R., Baldwin, M. R., Barr, R. G., Chang, B. P., Chau, K. H., Choi, J. J., Gavin, N., Goyal, P., Mills, A. M., Patel, A. A., Romney, M. S., Safford, M. M., Schluger, N. W., Sengupta, S., Sobieszczyk, M. E., Zucker, J. E., Asadourian, P. A., & Chen, R. (2020). Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ (Clinical research ed.), 369, m1996. https://doi.org/10.1136/bmj.m1996
Akalin, E., Azzi, Y., Bartash, R., Seethamraju, H., Parides, M., Hemmige, V., Ross, M., Forest, S., Goldstein, Y. D., Ajaimy, M., Liriano-Ward, L., Pynadath, C., Loarte-Campos, P., Nandigam, P. B., Graham, J., Le, M., Rocca, J., & Kinkhabwala, M. (2020). Covid-19 and Kidney Transplantation. The New England journal of medicine, 382(25), 2475–2477. https://doi.org/10.1056/NEJMc2011117
Asghar, M. S., Haider Kazmi, S. J., Khan, N. A., Akram, M., Hassan, M., Rasheed, U., & Ahmed Khan, S. (2020). Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country. Cureus, 12(8), e9575. https://doi.org/10.7759/cureus.9575
Atila, C., Sailer, C. O., Bassetti, S., Tschudin-Sutter, S., Bingisser, R., Siegemund, M., Osswald, S., Rentsch, K., Rueegg, M., Schaerli, S., Kuster, G. M., Twerenbold, R., & Christ-Crain, M. (2021). Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls. European journal of endocrinology, 184(3), 409–418. https://doi.org/10.1530/EJE-20-1374
Bastug, A., Bodur, H., Erdogan, S., Gokcinar, D., Kazancioglu, S., Kosovali, B. D., Ozbay, B. O., Gok, G., Turan, I. O., Yilmaz, G., Gonen, C. C., & Yilmaz, F. M. (2020). Clinical and laboratory features of COVID-19: Predictors of severe prognosis. International immunopharmacology, 88, 106950. https://doi.org/10.1016/j.intimp.2020.106950
Brasil. (2021). Boletim Epidemiológico Especial – Doença pelo Coronavírus COVID-19. Ministério da Saúde – Secretaria de Vigilância em Saúde.
Braz Amarilio da Cunha, D., Nakamura Perissê Pereira, C., Carneiro de Aguiar , Y., Godoi de Carvalho, S., Barrozo Fernandes Borges, J., Pinheiro São Pedro , J., & Fernandes dos Santos Castro , F. (2021). Uso de marcadores biológicos para avaliação prognóstica de pacientes com covid-19: uma revisão de literatura. RECIMA21 - Revista Científica Multidisciplinar. 2(6), e26436. https://doi.org/10.47820/recima21.v2i6.436
Colli, E. de H., Davalos, S. R. A., Benítez, D. F. D., Oliveira, F. A. de ., Campos, C. B. S., Pinheiro, M. E. de L., Tavares, M. A. de S. B., & Santos, T. F. dos . (2022). Complicações renais resultantes de infecção pelo vírus da SARS-CoV-2. Research, Society and Development, 11(8), e17411830276. https://doi.org/10.33448/rsd-v11i8.30276
Corrêa, T. D., Matos, G. F. J., Bravim, B. A., Cordioli, R. L., Garrido, A. D. P. G., Assuncao, M. S. C., Barbas, C. S. V., Timenetsky, K. T., Rodrigues, R. D. R., Guimarães, H. P., Rabello Filho, R., Lomar, F. P., Scarin, F. C. C., Batista, C. L., Pereira, A. J., Guerra, J. C. C., Carneiro, B. V., Nawa, R. K., & Brandão, R. M. (2020). Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection. Einstein (Sao Paulo, Brazil), 18, eCE5931. https://doi.org/10.31744/einstein_journal/2020ce5931
Eckart, A., Hausfater, P., Amin, D., Amin, A., Haubitz, S., Bernard, M., Baumgartner, A., Struja, T., Kutz, A., Christ-Crain, M., Huber, A., Mueller, B., & Schuetz, P. (2018). Hyponatremia and activation of vasopressin secretion are both independently associated with 30-day mortality: results of a multicenter, observational study. Journal of internal medicine, 284(3), 270–281. https://doi.org/10.1111/joim.12764
Elshazli, R. M., Toraih, E. A., Elgaml, A., El-Mowafy, M., El-Mesery, M., Amin, M. N., Hussein, M. H., Killackey, M. T., Fawzy, M. S., & Kandil, E. (2020). Diagnostic and prognostic value of hematological and immunological markers in covid-19 infection: a meta-analysis of 6320 patients. PLOS ONE, 15(8), E0238160. HTTPS://DOI.ORG/10.1371/JOURNAL.PONE.0238160
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S. C., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y., & China Medical Treatment Expert Group for Covid-19 (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA cardiology, 5(7), 811–818. https://doi.org/10.1001/jamacardio.2020.1017
Li, T., Lu, H., & Zhang, W. (2020). Clinical observation and management of COVID-19 patients. Emerging microbes & infections, 9(1), 687–690. https://doi.org/10.1080/22221751.2020.1741327
Liu, K., Chen, Y., Lin, R., Hu, W., Iv, X. & Li, C. (2020). Desordens sodio COVID Hu.af. Società Italiana di Medicina Interna (SIMI). 1-13.
Miljic, D., Miljic, P., Doknic, M., Pekic, S., Stojanovic, M., Petakov, M., & Popovic, V. (2014). Adipsic diabetes insipidus and venous thromboembolism (VTE): recommendations for addressing its hypercoagulability. Hormones (Athens, Greece), 13(3), 420–423. https://doi.org/10.14310/horm.2002.1496
Nigro, N., Winzeler, B., Suter-Widmer, I., Schuetz, P., Arici, B., Bally, M., Refardt, J., Betz, M., Gashi, G. & Urwyler, S.A. (2018). Níveis de Copeptina e parâmetros laboratoriais comumente usados em pacientes hospitalizados com hipernatremia grave — o "estudo Co-MED". Cuidados intensivos.
Oude Lansink-Hartgring, A., Hessels, L., Weigel, J., de Smet, A. M. G. A., Gommers, D., Panday, P. V. N., Hoorn, E. J., & Nijsten, M. W. (2016). Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Annals of intensive care, 6(1), 22. https://doi.org/10.1186/s13613-016-0124-x
Pecly, I. M. D., Azevedo, R. B., Muxfeldt, E. S., Botelho, B. G., Albuquerque, G.G., Diniz, P. H. P., Silva, R., & Rodrigues, C. I. S. (2021). Uma revisão da Covid-19 e lesão renal aguda: da fisiopatologia aos resultados clínicos. Braz. J. Nephrol., 43(4), 551-571.
Pereira, A. S., et al. (2018). Metodologia da pesquisa cientifica. UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1.
Qian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., Shi, C. W., Lian, X., Chu, J. G., Chen, L., Wang, Z. Y., Ren, D. W., Li, G. X., Chen, X. Q., Shen, H. J., & Chen, X. M. (2020). Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM: monthly journal of the Association of Physicians, 113(7), 474–481. https://doi.org/10.1093/qjmed/hcaa089
Simadibrata, D. M., & Lubis, A. M. (2020). D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis. Epidemiology and infection, 148, e202. https://doi.org/10.1017/S0950268820002022
Tzoulis, P., Waung, J. A., Bagkeris, E., Hussein, Z., Biddanda, A., Cousins, J., Dewsnip, A., Falayi, K., McCaughran, W., Mullins, C., Naeem, A., Nwokolo, M., Quah, H., Bitat, S., Deyab, E., Ponnampalam, S., Bouloux, P. M., Montgomery, H., & Baldeweg, S. E. (2021). Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19. The Journal of clinical endocrinology and metabolism, 106(6), 1637–1648. https://doi.org/10.1210/clinem/dgab107
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Bianca de Souza Lima; Isadora Latrônico Domingos; Victor Santos Coll ; Barbara dos Reis Dal Lago Rodrigues ; Felipe Sanches Carneiro; Celso Dal Lago Rodrigues Neto ; João Nelson dos Santos Rodrigues Filho; Geovanna Gonçalves Sousa; Arialdo Ferreira de Araújo Neto; Jéssica Vanessa Iglesias Furlaneto ; Bruna Franco Candia; Isadora Pertinhes Macerou ; Tauanne Fernanda dos Santos; Marco Antônio de Souza Borges Tavares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
